Medicine & Health

WashU Medicine is one of eight academic medical centers to be selected for the Edmond J. Safra Fellowship in Movement Disorders. The program will provide funding to train a movement disorder specialist in the Department of Neurology.

A WashU Medicine neuroscientist and fan of the Philadelphia Eagles, Jason Yi, has received a $400,000 grant to study autism spectrum disorder from the football team’s foundation.

WashU Medicine researchers showed that a popular antidepressant drug effectively reduced seizures for two sisters with a rare form of epilepsy.

A team led by WashU Medicine radiology associate professor Shuo Wang has identified neurons that appear to play a key role in our ability to recognize people.

WashU Medicine researchers have identified biomarkers of Alzheimer’s, Parkinson’s and frontotemporal dementia from blood plasma, suggesting new therapeutic avenues.

Biologist Keith Hengen in Arts & Sciences at Washington University in St. Louis says “criticality” is the key to understanding how the brain works — and how to keep it free from Alzheimer’s and other diseases.

The FDA has given market authorization to a WashU startup’s technology that quickly and accurately maps the sensitive areas in patients’ brains to help neurosurgeons plan safe and effective surgeries.

Jennifer Phillips-Cremins, a pioneer in understanding 3D genome structure and its impact on the brain, will join WashU Medicine as BJC Investigator.

Researchers at WashU and St. Jude Children’s Research Hospital have found that biomolecular condensates play a role in suppressing the effects of ALS-causing mutations.

A new study by WashU Medicine researchers suggests that lemborexant and sleep aids that work the same way could help treat or prevent damage caused by harmful buildup of the protein tau in multiple neurodegenerative diseases, including Alzheimer’s.